A plain-language guide Listed exclusions

Who the leaflet excludes

The maker’s list has limits of its own.

A contraindication is a reason a medicine’s information says it must not be used.

What the Russian leaflet says

The maker’s leaflet excludes pregnancy, breastfeeding, people under 18, and people who react badly to Selank.

It says use during pregnancy, breastfeeding, and childhood was not tested for benefit or safety.

This is the maker’s list, not a complete set of possible reasons for harm.

There is no official U.S. Selank medicine leaflet reviewed by FDA. So there is no FDA-reviewed list of people who must not use it.

The absence of a longer list cannot tell you that other situations are safe.

A care discussion can include pregnancy, plans for pregnancy, breastfeeding, prior reactions, and current medicines.

If a question feels personal, write it down first. You can read from your note during the visit.

How do my circumstances change which options we discuss?

The maker’s Russian leaflet
It supplies the exclusions and says these groups were not tested.
FDA: U.S. product record
The U.S. medicine information was checked on September 30, 2026.
FDA: missing human information
The broader harm question remains open.